Stem Cell Research and Therapy, Volume 13, Issue 1 , 01/12/2022

Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury (Stem Cell Research & Therapy, (2022), 13, 1, (167), 10.1186/s13287-022-02840-0)

Charlotte Sarre, Rafael Contreras-Lopez, Nitirut Nernpermpisooth, Christian Barrere, Sarah Bahraoui, Claudia Terraza, Gautier Tejedor, Anne Vincent, Patricia Luz-Crawford, Kantapich Kongpol, Sarawut Kumphune, Christophe Piot, Joel Nargeot, Christian Jorgensen, Farida Djouad, Stéphanie Barrere-Lemaire

Abstract

The original article contained errors in the attribution of affiliations which have since been corrected.

Document Type

Erratum

Source Type

Journal

ASJC Subject Area

Medicine : Medicine (miscellaneous)Biochemistry, Genetics and Molecular Biology : Biochemistry, Genetics and Molecular Biology (miscellaneous)Biochemistry, Genetics and Molecular Biology : Molecular MedicineBiochemistry, Genetics and Molecular Biology : Cell Biology

Access to Document

DOI : 10.1186/s13287-022-03086-6
Link to scopus


1

Citations (Scopus)

Bibliography


Sarre, C., Contreras-Lopez, R., Nernpermpisooth, N., Barrere, C., Bahraoui, S., Terraza, C., Tejedor, G., ... Barrere-Lemaire, S. (2022). Correction: PPARβ/δ priming enhances the anti-apoptotic and therapeutic properties of mesenchymal stromal cells in myocardial ischemia–reperfusion injury (Stem Cell Research & Therapy, (2022), 13, 1, (167), 10.1186/s13287-022-02840-0). Stem Cell Research and Therapy, 13(1) doi:10.1186/s13287-022-03086-6

Copy | Save